Production of IL-1Ra by human mononuclear blood cells in vitro: Influence of serum factors

Cytokine

Volumn 34, Issue 5-6, 2006, Pages 320-330

  Clinchy, Birgitta ^a   Gunnerås, Marie ^a   Håkansson, Annika ^a   Håkansson, Leif ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Human serum; IL 1Ra; Immunoglobulin; Mononuclear cells; Tissue culture

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADSORPTION; ARTICLE; BLOOD CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREGULATION; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; SERUM; SERUM FACTOR; TISSUE CULTURE;

BIOLOGICAL FACTORS; CELL ADHESION; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LEUKOCYTES, MONONUCLEAR; MYELOMA PROTEINS; PROTEIN BINDING; SERUM; SIALOGLYCOPROTEINS;

EID: 33747104808     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.06.010     Document Type: Article

References (39)

1. Arend W.P., Malyak M., Guthridge C.J., and Gabay C. Interelukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16 (1998) 27-55
2. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16 (1998) 457-499
3. Witkin S.S., Gerber S., and Ledger W.J. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 34 (2002) 204-209
4. Sehouli J., Mustea A., Könsgen D., Katsares I., and Lichtenegger W. Polymorphism of IL-1 receptor antagonist gene: role in cancer. Anticancer Res 22 (2002) 3421-3424
5. Chikanza I.C., Roux-Lombard P., Dayer J.M., and Panayi G.S. Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implications. Arthritis Rheum 38 (1995) 642-648
6. Arend W.P. Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist. Semin Arthritis Rheum 30 (2001) 1-6
7. Teppo A.M., Honkanen E., Ahonen J., and Gronhagen-Riska C. Does increased urinary interleukin-1 receptor antagonist/interleukin-1β ratio indicate good prognosis in renal transplant recipients?. Transplantation 66 (1998) 1009-1014
8. Vamvakopoulos J., Green C., and Metcalf S. Gentic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 32 (2002) 2988-2996
9. Dayer J.M., Fiege U., Edwards C.K., and Burger D. Anti-interleukin-1 therapy in rheumatic diseases. Curr Opin Rheumatol 13 (2001) 170-176
10. Kary S., and Burmester G.R. Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis. Intl J Clin Practice 57 (2003) 231-234
11. Antin J.H., Weinstein H.J., Guinan E.C., McCarthy P., Bierer B.E., Gilliland D.G., et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steriod-resistant graft-versus-host disease. Blood 84 (1994) 1342-1348
12. Antin J.H., Weisdorf D., Nueberg D., Nicklow R., Clouthier S., Lee S.J., et al. Interelukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation. Blood 100 (2002) 3479-3482
13. Kaminska J., Kowalska M.M., Nowacki M.P., Chwalinski M.G., Rysinska A., and Fuksiewicz M. CRP, TNF-α, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients. Pathol Oncol Res 6 (2000) 38-41
14. Miller L.J., Kurtzman S.H., Anderson K., Wang Y., Stankus M., Renna M., et al. Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist. Cancer Invest 18 (2000) 293-302
15. Smith D.R., Kunkel S.L., Standiford T.J., Chensue S.W., Rolfe M.W., Orringer M.B., et al. The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma. Am J Pathol 143 (1993) 794-803
16. Burger R.A., Grosen E.A., Ioli G.R., Van Eden M.E., Brightbill H.D., Gatanga M., et al. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro. Gynecol Oncol 55 (1994) 294-303
17. Fujiwaki R., Hata T., Miyazaki K., Kawamura T., and Inada K. Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers. Br J Obstet Gynacol 104 (1997) 1407-1408
18. Iizuka N., Hazama S., Hirose K., Abe T., Tokuda N., Fukumoto T., et al. Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma. Cancer Lett 142 (1999) 179-184
19. Oelmann E., Kraemer A., Serve H., Reufi B., Oberberg D., Patt S., et al. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1. Int J Cancer 71 (1997) 1066-1076
20. Wetzler M., Kurzrock R., Estrov Z., Kantarjian H., Gisslinger H., Underbrink M.P., et al. Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates. Blood 84 (1994) 3142-3147
21. Tao M., Li B., Nayini J., Andrews C.B., Huang R.W., Devemy E., et al. SCF, IL-1β, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients. Cytokine 12 (2000) 699-707
22. Arend W.P., and Leung D.Y.M. IgG induction of IL-1 receptor antagonist production by human monocytes. Immunol Rev 139 (1994) 71-78
23. Schur P.H., Chang D.-M., Baptiste P., Uhteg L.C., and Hanson D.C. Human monocytes produce IL-1 and an inhibitor of IL-1 in response to two different signals. Clin Immunol Immunopathol 57 (1990) 45-63
24. Poutsiaka D.D., Clark B.D., Vannier E., and Dinarello C.A. Production of interleukin-1 receptor antagonist and interleukin-1β by pheripheral blood mononuclear cells is differentially regulated. Blood 78 (1991) 1275-1281
25. Andersson J., Skansén-Saphir U., Sparrelid E., and Andersson U. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Clin Exp Immunol 104 (1996) 10-20
26. Ruiz de Souza V., Carreno M.P., Kaveri S.V., Ledur A., Sadeghi H., Cavaillon J.M., et al. Selective induction of interlukin-1 receptor antagonist and interlukin-6 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol 25 (1995) 1267-1273
27. Drenth J.P.H., Göertz J., Daha M.R., and van der Meer J.W. Immunoglobulin D enhances the release of tumour necrosis factor-α, and interleukin-1β as well as interleukin-1 receptor antagonist from human mononuclear cells. Immunology 88 (1996) 355-362
28. Shimamura H., Iwagaki H., Gouchi A., Morimoto Y., Ariki N., Funaki M., et al. Autologous serum deprivation restored IL-1 receptor antagonist production by peripheral blood mononuclear cells in patients with gastric cancer. J Int Med Res 28 (2000) 277-287
29. Smedegaard Andersen L., Petersen J., Svenson M., and Bendtzen K. IgG for intravenous use, autologous serum and plasma induce comparable interleukin-1 receptor antagonist liberation from human mononuclear cells: an in vitro phenomenon depending upon plastic adherence. Autoimmunity 22 (1995) 127-133
30. Clinchy B., Youssefi M.R., and Hakansson L. Differences in adsorption of serum proteins and production of IL-1ra by human monocytes incubated in different tissue culture microtiter plates. J Immunol Methods 282 (2003) 53-61
31. Lynch E.A., Dinarello C.A., and Cannon J.G. Gender differences in IL-1α, IL-1β and IL-1receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol 153 (1994) 300-306
32. Danis V.A., Millington M., Hyland V.J., and Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99 (1995) 303-310
33. van de Winkel J.G.J., and Capel P.J.A. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today 14 (1993) 215-221
34. Liou L.-B. Serum and in vitro IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol 19 (2001) 515-523
35. Grinnell F., and Feld M.K. Fibronectin adsorption on hydrophilic and hydrophobic surfaces detected by antibody binding and analyzed during cell adhesion in serum-containing medium. J Biol Chem 257 (1982) 4888-4893
36. Green R.J., Davies M.C., Roberts C.J., and Tendler S.J. Competitive protein adsorption as observed by plasmon resonance. Biomaterials 20 (1999) 385-391
37. Nilsson U.R. Deposition of C3b/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes. Mol Immunol 38 (2001) 151-160
38. Galon J., Paulet P., Galinha A., Lorés P., Bonnerot C., Jami J., et al. Soluble Fcγ receptors: interaction with ligands and biological consequences. Int Rev Immunol 16 (1997) 87-111
39. Jones R.H.V., Rademacher T.W., and Williams P.J. Bias in murine IgG isotype immobilisation. Implications for IgG glycoform analysis ELISA procedures. J Immunol Methods 197 (1996) 109-120